MARKETS
Markets

Autonomix Medical Awarded U.S. Patent For Autonomic Nervous System Assessment Systems, Kits, And Methods

Jul 23, 2026 · 07:32 AM ET· updated 2h ago

U.S. Patent No. 12,471,776, titled "ANS Assessment Systems, Kits, and Methods," broadly covers systems, devices and methods for monitoring physiologic signals to assess autonomic nervous system (ANS) activity,

Share
Why It Matters

Autonomix Medical got official government permission to be the only company using their special way to measure how your body's automatic systems are working. This is like getting a license that could help them sell their product, but it doesn't mean the product will definitely succeed.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.